On August 31, 2022, Dr. Adrian Kilcoyne informed Humanigen, Inc. of his resignation from his position as Chief Medical Officer of the Company, effective September 28, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -66.67% | -50.00% | -91.67% |
04-12 | Combined Liquidation Plan and Disclosure Statement Filed by Humanigen, Inc. | CI |
03-08 | Final DIP Financing Approved for Humanigen, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-91.67% | 11.91K | |
-2.91% | 89.01B | |
-4.34% | 37.79B | |
-17.08% | 31.22B | |
+60.52% | 26.1B | |
-22.15% | 14.25B | |
-9.36% | 12.8B | |
-11.39% | 11.65B | |
-46.06% | 10.88B | |
+3.22% | 8.7B |
- Stock Market
- Equities
- HGEN.Q Stock
- News Humanigen, Inc.
- Humanigen, Inc. Announces Resignation Adrian Kilcoyne as Chief Medical Officer, Effective September 28, 2022